UncategorizedMIRA Pharmaceuticals’ Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain 1 week ago01 mins MIRA Pharmaceuticals stock rises as new preclinical data reveal its oral ketamine analog Ketamir-2 is 60% more effective than gabapentin in pain relief. read more Post navigation Previous: Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike HigherNext: ‘Asia’s MicroStrategy’ Metaplanet Buys Another $10.4M In Bitcoin, Exceeds 1,000 BTC Holdings Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Rivian, Draftkings, Block, Pinterest, And Tesla: Why These 5 Stocks Are On Investors’ Radars Today 31 mins ago 0
Detroit Becomes First Major US City To Accept Taxes And Fees In Crypto; Mayor Says, ‘Fostering a Technology-Friendly Environment’ 1 hour ago 0
Obama-Era Economist Jason Furman Warns Fed’s Inflation Outlook May Be Too Optimistic — Peter Schiff Slams Powell’s Strategy Amid National Debt Concerns 1 hour ago 0